ARVEE · Arvee Laboratories (India) Limited · Financials
Market Cap
2.45B INR
Shares
11.02M
Volume · Nov 13
974
Avg daily vol (3M)
15.6K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
315.14M
-18.1%
FY2026
Net Income
25.26M
+17.7%
FY2026
Operating Cash Flow
-1.2M
-220.9%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|---|
| INR | 627.37M | 315.14M | 384.87M | 303.45M | 624.82M | 403.28M | 473.75M |
| INR | 12.68M | 12.14M | 11.49M | 14.98M | 20.8M | 23.2M | 24.07M |
| INR | 3.09M | 2.35M | 2.49M | 2.5M | 3.88M | 3.59M | 5.77M |
| INR | 78.79M | 24.31M | 28.71M | 18.3M | 61.65M | 34.49M | 36.41M |
| INR | 12.82M | -958K | 7.24M | 7.78M | 20.46M | 8.75M | 9.64M |
| INR | 65.97M | 25.26M | 21.47M | 10.52M | 41.19M | 0 | 0 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.